March 19, 2014
A New York federal judge on Wednesday agreed to move a whistleblower suit alleging Cephalon Inc. promoted some of its drugs for off-label uses to boost sales to government-funded programs, finding that a similar suit in Pennsylvania was filed first.
September 13, 2013
A whistleblower who once served as a senior-level manager at Cephalon Inc. urged a New York federal judge on Thursday to transfer his False Claims Act suit against the biopharmaceutical company to Pennsylvania federal court, where another similar case against the company is pending.
March 18, 2013
Cephalon Inc. was hit with a whistleblower suit in New York federal court Friday claiming the drugmaker submitted hundreds of thousands of false claims to federal and state health care programs by promoting its leukemia and pain medications for unapproved off-label uses.